Idenix Pharmaceuticals (IDIX)

[rwwine]

Quote
"yet the Street seems to be discounting this part of the IDIX pipeline completely."

Quote from me:
"IDIX—It doesn't seem to me that the IDX899 compound is considered and or appreciated by those covering IDIX when it comes to valuation."

From the Biotech Values Board yesterday morning.... DewDiligence response to what we all have been wondering about.....

I agree and I think there’s an explanation: Until recently, most investors thought GILD owned the HIV market lock, stock, and barrel. A corollary: these investors thought no company had a chance to gain any traction in HIV unless it was working directly with GILD. IDIX’s partner, GSK, was considered a hopeless also-ran in HIV.

These views appear to finally be softening to some degree. Most investors still think non-GILD HIV programs face long odds, but there’s a growing recognition, IMO, that other companies have a shot if they play their cards right. GSK’s program for the integrase inhibitor, ‘572, is case in point (#msg-52482079).